LAB2MARKET – HEALTH (L2M-H)
LAB2MARKET – HEALTH (L2M-H)
Lab2Market-Health (L2M-H) is a virtual adaption of Lab2Market (L2M), specifically designed to address the need for ‘path-to-market’ support for researchers solving pressing problems in the healthcare industry.
Over 7 weeks, L2M-H will prepare researchers to navigate the path to market for new health technologies, such as:
(a) Diagnostics, drugs and therapeutics, as well as medical devices in vaccinology, immunology and infectious diseases;
(b) Artificial Intelligence (AI) for prediction of infectious diseases and pandemics, new drug discovery and health system responses to pandemics;
(c Disease surveillance and health system innovation for pandemics and reducing the threat of epidemics through the development and use of innovative tools; and
(d) Digital and virtual health solutions.
EXPECTED COMMITMENT
The program requires a commitment of 25 hours per week. By the end of the program, participants will:
- Build critical thinking, collaboration, communication, innovation and entrepreneurship skills
- Define clinical utility before spending millions of dollars
- Understand their core customers, and the sales and marketing process required for initial clinical sales and downstream commercialization
- Assess intellectual property and regulatory risk before they design and build
- Gather data essential to customer partnerships/collaboration before doing the science
- Identify and understand financial vehicles
- Understand their regulatory pathway, and consulting with regulatory authorities
- Understanding their clinical pathway to market